Thomas Hammond, MD
Otolaryngology · Fairbanks, AKNPI 1356405492
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,582 of the $3,908 with a category attached, or 66.1%. 10 manufacturers reported payments, led by Medtronic at 51.0% of the total. Reporting peaked in 2022 at $2,025 and has fallen 94.4% since, to $114 in 2025.
Across 34 payments — averaging $114.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Stryker$1K
- GSK$391
- Merz North America, Inc.$165
- Sanofi$79
- Biocryst US Sales Co., LLC$43
- plus $110 from 4 others
What the payments were for
- Travel & lodging$2,58266%
- Food & beverage$1,32634%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $1,992 |
| Stryker | 4 | $1,128 |
| GSK | 14 | $391 |
| Merz North America, Inc. | 1 | $165 |
| Sanofi | 4 | $79 |
| Biocryst US Sales Co., LLC | 1 | $43 |
| Boston Scientific | 1 | $34 |
| Intersect ENT, Inc. | 1 | $31 |
| Genentech USA, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINUVA$1,071
- ENTELLUS - XPRESS ENT DILATION SYSTEM$1,066
- PROPEL$920
- NUCALA$125
How this compares
$3,908 in reported general payments places this provider in the 80th percentile of 20 otolaryngology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 57 | $1,331 |
| Olopatadine Hcl | 12 | $913 |
| Fluticasone Propionate | 32 | $210 |
| Famotidine | 15 | $135 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Fairbanks
- Sam KimFairbanks$1K
- Eugene SansoniWasilla$8K
- Jennifer MitchellWasilla$5K
- Jerome ListEagle River$4K
- Stephen SchafferAnchorage$2K
- Eli BressAnchorage$2K
- Khang LuAnchorage$2K
- Christopher KowalskiAnchorage$2K
- Mark LorenzAnchorage$1K
- John KokeshAnchorage$604
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.